These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18829251)

  • 1. [Bevacizumab-induced abdominal aortic thrombosis].
    Védrine L; Chargari C
    Presse Med; 2008 Dec; 37(12):1829-30. PubMed ID: 18829251
    [No Abstract]   [Full Text] [Related]  

  • 2. Aortic thrombosis in young women with Crohn's disease receiving adalimumab: report of two cases.
    Leblanc S; Lloret Linares C; Cacheux W; Mouthon L; Chaussade S
    Inflamm Bowel Dis; 2011 Mar; 17(3):862-3. PubMed ID: 20629181
    [No Abstract]   [Full Text] [Related]  

  • 3. Tonic-clonic seizures following intravitreal bevacizumab injection.
    Johnson D; Hollands H; Brox A; Sharma S
    Can J Ophthalmol; 2010 Apr; 45(2):186-7. PubMed ID: 20379317
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab, bleeding, thrombosis, and warfarin.
    Kilickap S; Abali H; Celik I
    J Clin Oncol; 2003 Sep; 21(18):3542; author reply 3543. PubMed ID: 12972536
    [No Abstract]   [Full Text] [Related]  

  • 5. Glomerular disease related to anti-VEGF therapy.
    Stokes MB; Erazo MC; D'Agati VD
    Kidney Int; 2008 Dec; 74(11):1487-91. PubMed ID: 18547991
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.
    Frangié C; Lefaucheur C; Medioni J; Jacquot C; Hill GS; Nochy D
    Lancet Oncol; 2007 Feb; 8(2):177-8. PubMed ID: 17267332
    [No Abstract]   [Full Text] [Related]  

  • 7. Bevacizumab: not as good with more adverse reactions?
    Beaumont P
    Clin Exp Ophthalmol; 2011 Aug; 39(6):588-90. PubMed ID: 21631687
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous thrombogenic vasculopathy associated with bevacizumab therapy.
    Kiuru M; Schwartz M; Magro C
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible posterior leukoencephalopathy syndrome and bevacizumab.
    Ozcan C; Wong SJ; Hari P
    N Engl J Med; 2006 Mar; 354(9):980-2; discussion 980-2. PubMed ID: 16514715
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible posterior leukoencephalopathy syndrome and bevacizumab.
    Glusker P; Recht L; Lane B
    N Engl J Med; 2006 Mar; 354(9):980-2; discussion 980-2. PubMed ID: 16510760
    [No Abstract]   [Full Text] [Related]  

  • 11. Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern.
    Avery RL
    J AAPOS; 2009 Aug; 13(4):329-31. PubMed ID: 19683181
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing patients treated with bevacizumab combination therapy.
    Gordon MS; Cunningham D
    Oncology; 2005; 69 Suppl 3():25-33. PubMed ID: 16301833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura.
    Cavalli G; Sallemi C; Berti A
    Br J Haematol; 2014 Aug; 166(4):470. PubMed ID: 24910114
    [No Abstract]   [Full Text] [Related]  

  • 14. Bevacizumab, sunitinib: osteonecrosis of the jaw.
    Prescrire Int; 2011 Jun; 20(117):155. PubMed ID: 21682016
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid progression of angioid streaks following intravitreal bevacizumab.
    Sen PR; Rishi P; Sen P; Rishi E; Shroff D
    Can J Ophthalmol; 2009 Oct; 44(5):e39-40. PubMed ID: 19798813
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy.
    Hsu JY; Wakelee HA
    BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab local complications.
    Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
    Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
    [No Abstract]   [Full Text] [Related]  

  • 18. Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy.
    Gore E; Currey A; Choong N
    J Thorac Oncol; 2009 Dec; 4(12):1590-1. PubMed ID: 20009916
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab: the need for controlled studies to move forward.
    Buys YM
    Can J Ophthalmol; 2007 Dec; 42(6):789. PubMed ID: 18059506
    [No Abstract]   [Full Text] [Related]  

  • 20. Papulopustular eruption after intravitreal bevacizumab (Avastin).
    Amselem L; Diaz-Llopis M; Garcia-Delpech S; Montero J; Palomares P; Cervera E
    Acta Ophthalmol; 2009 Feb; 87(1):110-1. PubMed ID: 18577190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.